Trial intelligence / Profile preview

Renin Profiling in Selection of Initial Antihypertensive Drug

NCT00834600Phase 4Completed

Sponsor
Louis and Rachel Rudin Foundation
Start
Dec 2005
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olmesartan in hypertension (HTN), sponsored by Louis and Rachel Rudin Foundation. Started Dec 2005; status: completed.

02

Drugs

olmesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00834600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00834600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call